{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
      "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno",
      "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
    },
    "document_metadata": {
      "authors": "Esther Wollert",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Naturally-expressed nicotinic acetylcholine receptor subtypes",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "DBSNP": "rs[0-9]+",
      "PUBCHEM": "^\\d+$",
      "TAXONOMY": "^\\d+$",
      "UNIPROT": "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\\.\\d+)?$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/501ceccdc9a27d97edbdc48a89ebe8e1dd3626e9/export/conso-names.belns",
      "DRUGBANK": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns",
      "ECCODE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/external/hgnc.genefamily-names.belns",
      "HP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns",
      "INTERPRO": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/interpro-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/mesh-names.belns",
      "MGI": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns",
      "NCBIGENE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns",
      "PFAM": "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/pfam-names.belns",
      "RGD": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/rgd-names.belns"
    },
    "path": "receptors/wu2011.bel",
    "pybel_version": "0.14.10"
  },
  "links": [
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "Moreover, some nAChRs have been implicated in processes such as the structuring and maintenance of neurites and synapses [18–20] and even in modulation of neuronal viability/death [21–24].",
      "key": "5404a5332c6c1ac30565211da564f078",
      "line": 79,
      "relation": "increases",
      "source": 34,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "Moreover, some nAChRs have been implicated in processes such as the structuring and maintenance of neurites and synapses [18–20] and even in modulation of neuronal viability/death [21–24].",
      "key": "6eca0fa701f97ce4b6241df80d6746fa",
      "line": 80,
      "relation": "increases",
      "source": 34,
      "target": 15
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "For example, Bgt-sensitive a7-nAChRs have been implicated in processes such as vicinal control of neurotransmitter release [7,14], development and maintenance of neurites and synapses [18–20], long-term potentiation [95,96], seizures [97], and neuronal viability/death [21–24]. These intriguing ﬁndings underscore the need for further characterization of functional a7-nAChRs.",
      "key": "24c318cddbc3b4e0c4a42bef0e39d5ea",
      "line": 166,
      "relation": "association",
      "source": 13,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "For example, Bgt-sensitive a7-nAChRs have been implicated in processes such as vicinal control of neurotransmitter release [7,14], development and maintenance of neurites and synapses [18–20], long-term potentiation [95,96], seizures [97], and neuronal viability/death [21–24]. These intriguing ﬁndings underscore the need for further characterization of functional a7-nAChRs.",
      "key": "e935e9469eb8d21e12dddb03aa1d17a0",
      "line": 167,
      "relation": "association",
      "source": 15,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "nAChRs that bind radiolabeled nicotine with the highest afﬁnity contain a4 subunits (a4*-nAChR; see reviews and/or tables by [1–7].",
      "key": "80856795e4b3ab28856a17f038d5e667",
      "line": 86,
      "relation": "increases",
      "source": 24,
      "target": 20
    },
    {
      "key": "70b78f081306f1c724667ab766e5dc7d",
      "relation": "partOf",
      "source": 5,
      "target": 24
    },
    {
      "key": "d4fc2ea356d58f27f0be25a26baee279",
      "relation": "partOf",
      "source": 5,
      "target": 20
    },
    {
      "key": "86b5fe39d7b6c4c9e9335d3ac1758206",
      "relation": "partOf",
      "source": 5,
      "target": 23
    },
    {
      "key": "d7ba4947a434a8e66eefc4d000824b41",
      "relation": "partOf",
      "source": 5,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "In terms of functional effects, nicotine acts acutely much in the way that ACh does, causing opening of nAChR channels.",
      "key": "e9e2fb55c2d3c472c5a8d0d406510f0f",
      "line": 122,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 5,
      "target": 34
    },
    {
      "key": "8b1b7cdeeadb335729f9bee29ff010cf",
      "relation": "partOf",
      "source": 29,
      "target": 24
    },
    {
      "key": "9689afbfa1a8ee453a3a6211ec135ea3",
      "relation": "partOf",
      "source": 29,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": " a4b2-nAChRs have been implicated in nicotine self-administration, reward, and depen- dence, and in diseases such as Alzheimer’s and epilepsy [1–5,27–33].",
      "key": "746253a296453b8d384addd771f987b6",
      "line": 93,
      "relation": "association",
      "source": 22,
      "target": 40
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": " a4b2-nAChRs have been implicated in nicotine self-administration, reward, and depen- dence, and in diseases such as Alzheimer’s and epilepsy [1–5,27–33].",
      "key": "a9f5028b4bfcaf8f11782ff4ddd82e4c",
      "line": 94,
      "relation": "association",
      "source": 22,
      "target": 44
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": " a4b2-nAChRs have been implicated in nicotine self-administration, reward, and depen- dence, and in diseases such as Alzheimer’s and epilepsy [1–5,27–33].",
      "key": "61f51abde74ceddfc6fbce2a4568de16",
      "line": 95,
      "relation": "association",
      "source": 22,
      "target": 39
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": " a4b2-nAChRs have been implicated in nicotine self-administration, reward, and depen- dence, and in diseases such as Alzheimer’s and epilepsy [1–5,27–33].",
      "key": "98dd977f5f2a2d07e60582b22cb4d1fd",
      "line": 96,
      "relation": "association",
      "source": 22,
      "target": 42
    },
    {
      "key": "54b41f61b3406da4415e9ce67a9554fa",
      "relation": "partOf",
      "source": 35,
      "target": 22
    },
    {
      "key": "fb54e4841c4128595c202abfeef6f1b6",
      "relation": "partOf",
      "source": 35,
      "target": 25
    },
    {
      "key": "c5d296b24470651adba11af6a372eebe",
      "relation": "partOf",
      "source": 37,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": " a4b2-nAChRs have been implicated in nicotine self-administration, reward, and depen- dence, and in diseases such as Alzheimer’s and epilepsy [1–5,27–33].",
      "key": "740877e87bd8df24358875233ea8dd58",
      "line": 93,
      "relation": "association",
      "source": 40,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": " b4 subunit mRNA colocalizes with a4 subunit mRNA in many brain regions [37,38] that could be involved in complex behaviors including nicotine dependence.",
      "key": "69b89941077cc52618d061f42a7f42fe",
      "line": 114,
      "relation": "association",
      "source": 40,
      "target": 26
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": " This makes the hypothesis particularly intriguing that a6*-nAChRs play roles in nicotine dependence.",
      "key": "8c54c011f473feb36be207d4e73ff6b9",
      "line": 245,
      "relation": "association",
      "source": 40,
      "target": 30
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": " a4b2-nAChRs have been implicated in nicotine self-administration, reward, and depen- dence, and in diseases such as Alzheimer’s and epilepsy [1–5,27–33].",
      "key": "14c272176e54227aed5f8b8ee22cb479",
      "line": 94,
      "relation": "association",
      "source": 44,
      "target": 22
    },
    {
      "annotations": {
        "Cell": {
          "midbrain dopaminergic neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "a6 subunits are not widely expressed in the brain, but they are prevalent in midbrain dopaminergic (DAergic) regions associated with pleasure, reward, and mood control ",
      "key": "4d090790b83e208829a2b20ea01cad96",
      "line": 191,
      "relation": "association",
      "source": 44,
      "target": 30
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "There is an emerging consensus that nAChR a6 subunit mRNA and proteins are distributed in brain regions thought to be involved in reward and drug reinforcement, in theory being involved in DA release [135]. ",
      "key": "dc544347d97f27436a80a48d5be8c858",
      "line": 233,
      "relation": "association",
      "source": 44,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "There is an emerging consensus that nAChR a6 subunit mRNA and proteins are distributed in brain regions thought to be involved in reward and drug reinforcement, in theory being involved in DA release [135]. ",
      "key": "4cb6c9d8d8f7c91e77673563d7373561",
      "line": 236,
      "relation": "association",
      "source": 44,
      "target": 36
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": " a4b2-nAChRs have been implicated in nicotine self-administration, reward, and depen- dence, and in diseases such as Alzheimer’s and epilepsy [1–5,27–33].",
      "key": "2f05ad163f0dea01f23e65fbbaa750da",
      "line": 95,
      "relation": "association",
      "source": 39,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": " a4b2-nAChRs have been implicated in nicotine self-administration, reward, and depen- dence, and in diseases such as Alzheimer’s and epilepsy [1–5,27–33].",
      "key": "905c31d344de5b36beefa21b41b9e28e",
      "line": 96,
      "relation": "association",
      "source": 42,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "a4 subunits can also assemble with b4 subunits to form a4b4-nAChRs that have comparably high nicotine afﬁnity [34–36].",
      "key": "a4e010a950a65e98daa758cf95cb3e2a",
      "line": 103,
      "relation": "increases",
      "source": 25,
      "target": 28
    },
    {
      "key": "a503f0ded7acd0381acf724a8ca4716a",
      "relation": "partOf",
      "source": 38,
      "target": 25
    },
    {
      "key": "7b40101bf4f0e366958de1c490c71c29",
      "relation": "partOf",
      "source": 28,
      "target": 23
    },
    {
      "key": "f0da23629204d4766e06a32eab219c6a",
      "relation": "partOf",
      "source": 28,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "a4 subunits can also assemble with b4 subunits to form a4b4-nAChRs that have comparably high nicotine afﬁnity [34–36].",
      "key": "fff90773cda0b35e2a6ea8fe89bee858",
      "line": 104,
      "relation": "increases",
      "source": 23,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": " b4 subunit mRNA colocalizes with a4 subunit mRNA in many brain regions [37,38] that could be involved in complex behaviors including nicotine dependence.",
      "key": "24da7e66bdf7fddea6d89dce99fc77c7",
      "line": 113,
      "relation": "association",
      "source": 46,
      "target": 48
    },
    {
      "key": "97694903d8872079dda361b9ddc76697",
      "relation": "partOf",
      "source": 46,
      "target": 26
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": " b4 subunit mRNA colocalizes with a4 subunit mRNA in many brain regions [37,38] that could be involved in complex behaviors including nicotine dependence.",
      "key": "8830b7b94b3f2e83f11f8da8516cbab5",
      "line": 113,
      "relation": "association",
      "source": 48,
      "target": 46
    },
    {
      "key": "03b9219d1c29b0d60c2688937dd47e19",
      "relation": "partOf",
      "source": 48,
      "target": 26
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": " b4 subunit mRNA colocalizes with a4 subunit mRNA in many brain regions [37,38] that could be involved in complex behaviors including nicotine dependence.",
      "key": "c2f18247b5e42378aab93dd195019d10",
      "line": 114,
      "relation": "association",
      "source": 26,
      "target": 40
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "In terms of functional effects, nicotine acts acutely much in the way that ACh does, causing opening of nAChR channels.",
      "key": "481ca9584b1e2f76bcd2361687170037",
      "line": 123,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 3,
      "target": 34
    },
    {
      "key": "2698a0cdee10400a9007d9c4dcb43c47",
      "relation": "partOf",
      "source": 31,
      "target": 21
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "Subsequently, renewed searches for functions of natural Bgt-binding nAChRs uncovered short-lived, nicotine-gated, toxin-sensitive, inward currents and/ or elevations of intracellular Ca2+ in chick autonomic neurons [84], in human ganglionic neuron-like clonal cells [85], or in rat CNS neurons [16,40–44,86–91].",
      "key": "2c4714b1960cfa52c48e611bd76f486a",
      "line": 145,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Extracellular Space",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Intracellular Space",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 31,
      "target": 1
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "By virtue of their unique subcellular localizations, channel kinetics and Ca2+ permeability, a7-nAChRs appear to have novel functional roles in addition to (i.e., distinct from) the mediation of classical excitatory neurotransmission. ",
      "key": "2c425e7176f79103efe100f35b35506b",
      "line": 154,
      "relation": "regulates",
      "source": 31,
      "target": 11
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "For example, Bgt-sensitive a7-nAChRs have been implicated in processes such as vicinal control of neurotransmitter release [7,14], development and maintenance of neurites and synapses [18–20], long-term potentiation [95,96], seizures [97], and neuronal viability/death [21–24]. These intriguing ﬁndings underscore the need for further characterization of functional a7-nAChRs.",
      "key": "64381c5583693ef1b3b2a3af9919b077",
      "line": 165,
      "relation": "association",
      "source": 31,
      "target": 16
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "For example, Bgt-sensitive a7-nAChRs have been implicated in processes such as vicinal control of neurotransmitter release [7,14], development and maintenance of neurites and synapses [18–20], long-term potentiation [95,96], seizures [97], and neuronal viability/death [21–24]. These intriguing ﬁndings underscore the need for further characterization of functional a7-nAChRs.",
      "key": "56efd75501528ee0a4a1807156f106b7",
      "line": 166,
      "relation": "association",
      "source": 31,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "For example, Bgt-sensitive a7-nAChRs have been implicated in processes such as vicinal control of neurotransmitter release [7,14], development and maintenance of neurites and synapses [18–20], long-term potentiation [95,96], seizures [97], and neuronal viability/death [21–24]. These intriguing ﬁndings underscore the need for further characterization of functional a7-nAChRs.",
      "key": "cbf897c4a58e766296e986e439c429e3",
      "line": 167,
      "relation": "association",
      "source": 31,
      "target": 15
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "For example, Bgt-sensitive a7-nAChRs have been implicated in processes such as vicinal control of neurotransmitter release [7,14], development and maintenance of neurites and synapses [18–20], long-term potentiation [95,96], seizures [97], and neuronal viability/death [21–24]. These intriguing ﬁndings underscore the need for further characterization of functional a7-nAChRs.",
      "key": "e238c978a954c4394e8bd74b55391ac2",
      "line": 168,
      "relation": "association",
      "source": 31,
      "target": 12
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "For example, Bgt-sensitive a7-nAChRs have been implicated in processes such as vicinal control of neurotransmitter release [7,14], development and maintenance of neurites and synapses [18–20], long-term potentiation [95,96], seizures [97], and neuronal viability/death [21–24]. These intriguing ﬁndings underscore the need for further characterization of functional a7-nAChRs.",
      "key": "33d19573000bc80c535acaf98d718bcf",
      "line": 169,
      "relation": "association",
      "source": 31,
      "target": 45
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "For example, Bgt-sensitive a7-nAChRs have been implicated in processes such as vicinal control of neurotransmitter release [7,14], development and maintenance of neurites and synapses [18–20], long-term potentiation [95,96], seizures [97], and neuronal viability/death [21–24]. These intriguing ﬁndings underscore the need for further characterization of functional a7-nAChRs.",
      "key": "94b75bcc2ee0f1daef9de7ed35f2d984",
      "line": 170,
      "relation": "association",
      "source": 31,
      "target": 14
    },
    {
      "key": "102a13bf1ab28970afbb57ea05cc1368",
      "relation": "partOf",
      "source": 32,
      "target": 21
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "For example, Bgt-sensitive a7-nAChRs have been implicated in processes such as vicinal control of neurotransmitter release [7,14], development and maintenance of neurites and synapses [18–20], long-term potentiation [95,96], seizures [97], and neuronal viability/death [21–24]. These intriguing ﬁndings underscore the need for further characterization of functional a7-nAChRs.",
      "key": "37b71546757a5179465bb20ffabdd59c",
      "line": 165,
      "relation": "association",
      "source": 16,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "For example, Bgt-sensitive a7-nAChRs have been implicated in processes such as vicinal control of neurotransmitter release [7,14], development and maintenance of neurites and synapses [18–20], long-term potentiation [95,96], seizures [97], and neuronal viability/death [21–24]. These intriguing ﬁndings underscore the need for further characterization of functional a7-nAChRs.",
      "key": "72ce3a70ac35fd9d23d05a9529d78f8d",
      "line": 168,
      "relation": "association",
      "source": 12,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "For example, Bgt-sensitive a7-nAChRs have been implicated in processes such as vicinal control of neurotransmitter release [7,14], development and maintenance of neurites and synapses [18–20], long-term potentiation [95,96], seizures [97], and neuronal viability/death [21–24]. These intriguing ﬁndings underscore the need for further characterization of functional a7-nAChRs.",
      "key": "b09db9bbe9c13e87e891beca10fbc9d2",
      "line": 169,
      "relation": "association",
      "source": 45,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "For example, Bgt-sensitive a7-nAChRs have been implicated in processes such as vicinal control of neurotransmitter release [7,14], development and maintenance of neurites and synapses [18–20], long-term potentiation [95,96], seizures [97], and neuronal viability/death [21–24]. These intriguing ﬁndings underscore the need for further characterization of functional a7-nAChRs.",
      "key": "3f7687efe3ec4c6c963a8e770778fbd8",
      "line": 170,
      "relation": "association",
      "source": 14,
      "target": 31
    },
    {
      "key": "115ec4dbb4b2f78a94354500b3f24c54",
      "relation": "partOf",
      "source": 0,
      "target": 18
    },
    {
      "key": "07d72cd16d245050751fdceceb56a678",
      "relation": "partOf",
      "source": 6,
      "target": 18
    },
    {
      "annotations": {
        "Cell": {
          "midbrain dopaminergic neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "a6 subunits are not widely expressed in the brain, but they are prevalent in midbrain dopaminergic (DAergic) regions associated with pleasure, reward, and mood control ",
      "key": "b375cccb42109e56fbe25a022a31d527",
      "line": 190,
      "relation": "association",
      "source": 30,
      "target": 43
    },
    {
      "annotations": {
        "Cell": {
          "midbrain dopaminergic neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "a6 subunits are not widely expressed in the brain, but they are prevalent in midbrain dopaminergic (DAergic) regions associated with pleasure, reward, and mood control ",
      "key": "bb2519402045a17ecbf33d285e8be6e7",
      "line": 191,
      "relation": "association",
      "source": 30,
      "target": 44
    },
    {
      "annotations": {
        "Cell": {
          "midbrain dopaminergic neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "a6 subunits are not widely expressed in the brain, but they are prevalent in midbrain dopaminergic (DAergic) regions associated with pleasure, reward, and mood control ",
      "key": "b543465f34da779d0db453b3c0734b62",
      "line": 192,
      "relation": "association",
      "source": 30,
      "target": 41
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "GABAergic Neurons": true,
          "Presynaptic Terminals": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": " Recently, we reported a novel discovery that functional a6*-nAChRs are located on GABAergic presynaptic boutons associated with VTA DAergic neurons, where these a6*- nAChRs mediate nicotinic modulation of GABA release onto those DAergic neurons [122].",
      "key": "493592a561644f13e77daf5e9d489e54",
      "line": 203,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "regulates",
      "source": 30,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": " This makes the hypothesis particularly intriguing that a6*-nAChRs play roles in nicotine dependence.",
      "key": "dfb06715b00a5d3adfe4e4a21b31a2a3",
      "line": 245,
      "relation": "association",
      "source": 30,
      "target": 40
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "There is good evidence that a6*-nAChRs, in particular, modulate neurotransmitter release in multiple brain regions.",
      "key": "02a4c653af3eee80cc6312caf53d56ea",
      "line": 252,
      "relation": "regulates",
      "source": 30,
      "target": 16
    },
    {
      "annotations": {
        "Cell": {
          "midbrain dopaminergic neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "a6 subunits are not widely expressed in the brain, but they are prevalent in midbrain dopaminergic (DAergic) regions associated with pleasure, reward, and mood control ",
      "key": "ce3588b4423e7505915b322834b8bb55",
      "line": 190,
      "relation": "association",
      "source": 43,
      "target": 30
    },
    {
      "annotations": {
        "Cell": {
          "midbrain dopaminergic neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "a6 subunits are not widely expressed in the brain, but they are prevalent in midbrain dopaminergic (DAergic) regions associated with pleasure, reward, and mood control ",
      "key": "f51fb5af9c642b4be2ac3bf2b95f0a21",
      "line": 192,
      "relation": "association",
      "source": 41,
      "target": 30
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "Initially, a-CtxMII was thought to be highly selective for a3b2*-nAChRs [124] and became a useful tool for investigating receptor structure [125].",
      "key": "4d9d19801873554dbf84f7d3ac1a9313",
      "line": 211,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 7,
      "target": 27
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "GABAergic Neurons": true,
          "Presynaptic Terminals": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": " Also, Endo et al. [141] found naturally-expressed a3b2- and a6b2-nAChRs on superior colli- culus neurons, and these receptors are likely located on pre- synaptic terminals of GABAergic neurons where they modulate GABA release.",
      "key": "655a29a4bfde4e4702b955413f47b5a6",
      "line": 263,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "regulates",
      "source": 27,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "Other ‘‘a3b2-speciﬁc’’ antagonists, such as neuronal- or kappa- bungarotoxin and a-CtxPnIA, have also turned out to block a6*- nAChRs [129].",
      "key": "ab8ac8d488805128564b2c678bfb5e2c",
      "line": 219,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 10,
      "target": 27
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "Other ‘‘a3b2-speciﬁc’’ antagonists, such as neuronal- or kappa- bungarotoxin and a-CtxPnIA, have also turned out to block a6*- nAChRs [129].",
      "key": "7d9fff8ec6444e4fa8f747da11236a9a",
      "line": 222,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 10,
      "target": 30
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "Other ‘‘a3b2-speciﬁc’’ antagonists, such as neuronal- or kappa- bungarotoxin and a-CtxPnIA, have also turned out to block a6*- nAChRs [129].",
      "key": "acf6ef2bfc3b6b73d639cf206da9fb96",
      "line": 220,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 33,
      "target": 27
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "Other ‘‘a3b2-speciﬁc’’ antagonists, such as neuronal- or kappa- bungarotoxin and a-CtxPnIA, have also turned out to block a6*- nAChRs [129].",
      "key": "e1843d167f0060c268fc8a32b9d51425",
      "line": 223,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 33,
      "target": 30
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "Other ‘‘a3b2-speciﬁc’’ antagonists, such as neuronal- or kappa- bungarotoxin and a-CtxPnIA, have also turned out to block a6*- nAChRs [129].",
      "key": "86d447206349fc1a9fa3397ce4f8756a",
      "line": 221,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 8,
      "target": 27
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "Other ‘‘a3b2-speciﬁc’’ antagonists, such as neuronal- or kappa- bungarotoxin and a-CtxPnIA, have also turned out to block a6*- nAChRs [129].",
      "key": "eb50806201a91a2d0beb471ec8d6888e",
      "line": 224,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 8,
      "target": 30
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "There is an emerging consensus that nAChR a6 subunit mRNA and proteins are distributed in brain regions thought to be involved in reward and drug reinforcement, in theory being involved in DA release [135]. ",
      "key": "5bab652d7d30a0c3955b927f7efd7427",
      "line": 233,
      "relation": "association",
      "source": 47,
      "target": 44
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "There is an emerging consensus that nAChR a6 subunit mRNA and proteins are distributed in brain regions thought to be involved in reward and drug reinforcement, in theory being involved in DA release [135]. ",
      "key": "4376a1e1925fc3638bb28473b4f9dfb2",
      "line": 234,
      "relation": "association",
      "source": 47,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "There is an emerging consensus that nAChR a6 subunit mRNA and proteins are distributed in brain regions thought to be involved in reward and drug reinforcement, in theory being involved in DA release [135]. ",
      "key": "12680b4657e06ebea200c05375c501c7",
      "line": 235,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "association",
      "source": 47,
      "target": 4
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "There is an emerging consensus that nAChR a6 subunit mRNA and proteins are distributed in brain regions thought to be involved in reward and drug reinforcement, in theory being involved in DA release [135]. ",
      "key": "b89a273184b3214178bba8f80b5148c3",
      "line": 234,
      "relation": "association",
      "source": 17,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "There is an emerging consensus that nAChR a6 subunit mRNA and proteins are distributed in brain regions thought to be involved in reward and drug reinforcement, in theory being involved in DA release [135]. ",
      "key": "b186e14513b2edcd3a948ddd3f053e19",
      "line": 237,
      "relation": "association",
      "source": 17,
      "target": 36
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "There is an emerging consensus that nAChR a6 subunit mRNA and proteins are distributed in brain regions thought to be involved in reward and drug reinforcement, in theory being involved in DA release [135]. ",
      "key": "a1302b268f77d19f7fa826c205b47865",
      "line": 235,
      "relation": "association",
      "source": 4,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "There is an emerging consensus that nAChR a6 subunit mRNA and proteins are distributed in brain regions thought to be involved in reward and drug reinforcement, in theory being involved in DA release [135]. ",
      "key": "15381b2691d679741de1e2cf31ef1b76",
      "line": 238,
      "relation": "association",
      "source": 4,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "target": 36
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "There is an emerging consensus that nAChR a6 subunit mRNA and proteins are distributed in brain regions thought to be involved in reward and drug reinforcement, in theory being involved in DA release [135]. ",
      "key": "7d87222d9b6e390c4beb69fb800282f4",
      "line": 236,
      "relation": "association",
      "source": 36,
      "target": 44
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "There is an emerging consensus that nAChR a6 subunit mRNA and proteins are distributed in brain regions thought to be involved in reward and drug reinforcement, in theory being involved in DA release [135]. ",
      "key": "209dc5706787ce1e586122cfb90e21ed",
      "line": 237,
      "relation": "association",
      "source": 36,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": "There is an emerging consensus that nAChR a6 subunit mRNA and proteins are distributed in brain regions thought to be involved in reward and drug reinforcement, in theory being involved in DA release [135]. ",
      "key": "9611a572ff72fa69181056bb1e49397d",
      "line": 238,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "association",
      "source": 36,
      "target": 4
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "GABAergic Neurons": true,
          "Presynaptic Terminals": true
        }
      },
      "citation": {
        "authors": [
          "Lukas RJ",
          "Wu J"
        ],
        "date": "2011-10-15",
        "db": "PubMed",
        "db_id": "21787755",
        "db_name": "Naturally-expressed nicotinic acetylcholine receptor subtypes.",
        "first": "Wu J",
        "journal": "Biochemical pharmacology",
        "last": "Lukas RJ",
        "pages": "800-7",
        "volume": "82"
      },
      "evidence": " Also, Endo et al. [141] found naturally-expressed a3b2- and a6b2-nAChRs on superior colli- culus neurons, and these receptors are likely located on pre- synaptic terminals of GABAergic neurons where they modulate GABA release.",
      "key": "f05ebccca01203a8d17514399aa18c84",
      "line": 264,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "regulates",
      "source": 9,
      "target": 2
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"amyloid-beta\")",
      "concept": {
        "name": "amyloid-beta",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "e9557ea6ec74113b73fe23f4bd76b524"
    },
    {
      "bel": "a(CHEBI:\"calcium(2+)\")",
      "concept": {
        "name": "calcium(2+)",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "94df77a2db8d9014b42535235da90e5d"
    },
    {
      "bel": "a(CHEBI:\"gamma-aminobutyric acid\")",
      "concept": {
        "name": "gamma-aminobutyric acid",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "de151e035b8e17ac675ada95b66a6db6"
    },
    {
      "bel": "a(CHEBI:acetylcholine)",
      "concept": {
        "name": "acetylcholine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "ff868385e5c4b568faf7e1eaa79ba0c4"
    },
    {
      "bel": "a(CHEBI:dopamine)",
      "concept": {
        "name": "dopamine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "4c950dc480c64069e58998401b2083c1"
    },
    {
      "bel": "a(CHEBI:nicotine)",
      "concept": {
        "name": "nicotine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "44ed555f78bacda2933ddef1d4280ce9"
    },
    {
      "bel": "a(CONSO:\"alpha-7 beta-2 nAChR\")",
      "concept": {
        "name": "alpha-7 beta-2 nAChR",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "a4bd5eee8df29cdd1ed693bbdb319bdc"
    },
    {
      "bel": "a(MESH:\"alpha-conotoxin MII\")",
      "concept": {
        "name": "alpha-conotoxin MII",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "2268253d9a306cddf171545f2163ba39"
    },
    {
      "bel": "a(MESH:\"alpha-conotoxin PnIA\")",
      "concept": {
        "name": "alpha-conotoxin PnIA",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "354830cc5b6089c4d7c1cc9f54d4e6b8"
    },
    {
      "bel": "a(MESH:\"alpha6beta2 nicotinic acetylcholine receptor\")",
      "concept": {
        "name": "alpha6beta2 nicotinic acetylcholine receptor",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "82ea1a37545d47fd73056b0e0e41b7c2"
    },
    {
      "bel": "a(MESH:\"neuronal bungarotoxin\")",
      "concept": {
        "name": "neuronal bungarotoxin",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "4ba5c9f8cd770f37271cff37e554bf63"
    },
    {
      "bel": "bp(GO:\"excitatory chemical synaptic transmission\")",
      "concept": {
        "name": "excitatory chemical synaptic transmission",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "5b872992e7f5fd9c51967ce1f4c9a252"
    },
    {
      "bel": "bp(GO:\"long-term synaptic potentiation\")",
      "concept": {
        "name": "long-term synaptic potentiation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "ab5cdc5c0ef7a3c4b3461ab4dcfa6730"
    },
    {
      "bel": "bp(GO:\"maintenance of synapse structure\")",
      "concept": {
        "name": "maintenance of synapse structure",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "a09a837526cf78a03f4f0d8f364f9ff7"
    },
    {
      "bel": "bp(GO:\"neuron death\")",
      "concept": {
        "name": "neuron death",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "5af039c1f3120f7215931236c3c03804"
    },
    {
      "bel": "bp(GO:\"neuron projection maintenance\")",
      "concept": {
        "name": "neuron projection maintenance",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "e229f723934b57456d74b7d066c4330a"
    },
    {
      "bel": "bp(GO:\"neurotransmitter secretion\")",
      "concept": {
        "name": "neurotransmitter secretion",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "ec4b7a70780da73311c0a0f3ee438d8d"
    },
    {
      "bel": "bp(MESH:\"Drug Interactions\")",
      "concept": {
        "name": "Drug Interactions",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "a203d4e1398ba6e272be3ad4da8eec37"
    },
    {
      "bel": "complex(a(CHEBI:\"amyloid-beta\"), a(CONSO:\"alpha-7 beta-2 nAChR\"))",
      "function": "Complex",
      "id": "8e901a2b6d43a8db0296d959cc688835",
      "members": [
        {
          "bel": "a(CHEBI:\"amyloid-beta\")",
          "concept": {
            "name": "amyloid-beta",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "e9557ea6ec74113b73fe23f4bd76b524"
        },
        {
          "bel": "a(CONSO:\"alpha-7 beta-2 nAChR\")",
          "concept": {
            "name": "alpha-7 beta-2 nAChR",
            "namespace": "CONSO"
          },
          "function": "Abundance",
          "id": "a4bd5eee8df29cdd1ed693bbdb319bdc"
        }
      ]
    },
    {
      "bel": "complex(a(CHEBI:nicotine), p(CONSO:\"alpha-4 beta-4 nAChR\"))",
      "function": "Complex",
      "id": "399a5314fe33b060174e77d3f2f4def6",
      "members": [
        {
          "bel": "a(CHEBI:nicotine)",
          "concept": {
            "name": "nicotine",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "44ed555f78bacda2933ddef1d4280ce9"
        },
        {
          "bel": "p(CONSO:\"alpha-4 beta-4 nAChR\")",
          "concept": {
            "name": "alpha-4 beta-4 nAChR",
            "namespace": "CONSO"
          },
          "function": "Protein",
          "id": "873b2da5332d7dcc0aeede964db13059"
        }
      ]
    },
    {
      "bel": "complex(a(CHEBI:nicotine), p(CONSO:\"alpha-4-containing nAChR\"))",
      "function": "Complex",
      "id": "396042523d83bd6d4e963fe8f6fdb3ff",
      "members": [
        {
          "bel": "a(CHEBI:nicotine)",
          "concept": {
            "name": "nicotine",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "44ed555f78bacda2933ddef1d4280ce9"
        },
        {
          "bel": "p(CONSO:\"alpha-4-containing nAChR\")",
          "concept": {
            "name": "alpha-4-containing nAChR",
            "namespace": "CONSO"
          },
          "function": "Protein",
          "id": "f5c643bbd5a70416e56c39f2b2d495c2"
        }
      ]
    },
    {
      "bel": "complex(p(CONSO:\"alpha-7-containing nAChR\"), p(CONSO:\"alpha-Bungarotoxin\"))",
      "function": "Complex",
      "id": "74a4a5d9540078a625c399eaf6471cce",
      "members": [
        {
          "bel": "p(CONSO:\"alpha-7-containing nAChR\")",
          "concept": {
            "name": "alpha-7-containing nAChR",
            "namespace": "CONSO"
          },
          "function": "Protein",
          "id": "f345684f49a458ac116337ace3fb3a87"
        },
        {
          "bel": "p(CONSO:\"alpha-Bungarotoxin\")",
          "concept": {
            "name": "alpha-Bungarotoxin",
            "namespace": "CONSO"
          },
          "function": "Protein",
          "id": "d6460fe2ee89d7c056254242689427e3"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:CHRNA4), p(HGNC:CHRNB2))",
      "function": "Complex",
      "id": "f9f1024ba6ba98f08a6c55cdddb54011",
      "members": [
        {
          "bel": "p(HGNC:CHRNA4)",
          "concept": {
            "name": "CHRNA4",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "80f72d8d35ebd95851a4fbebf17fce4b"
        },
        {
          "bel": "p(HGNC:CHRNB2)",
          "concept": {
            "name": "CHRNB2",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7e5d65d97e555667e0928696d86663e6"
        }
      ]
    },
    {
      "bel": "composite(a(CHEBI:nicotine), p(CONSO:\"alpha-4 beta-4 nAChR\"))",
      "function": "Composite",
      "id": "bd5b93e6b3d0183750a79707b3777676",
      "members": [
        {
          "bel": "a(CHEBI:nicotine)",
          "concept": {
            "name": "nicotine",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "44ed555f78bacda2933ddef1d4280ce9"
        },
        {
          "bel": "p(CONSO:\"alpha-4 beta-4 nAChR\")",
          "concept": {
            "name": "alpha-4 beta-4 nAChR",
            "namespace": "CONSO"
          },
          "function": "Protein",
          "id": "873b2da5332d7dcc0aeede964db13059"
        }
      ]
    },
    {
      "bel": "composite(a(CHEBI:nicotine), p(CONSO:\"alpha-4-containing nAChR\"))",
      "function": "Composite",
      "id": "50efb82fa06e1aaeb168ef1a591ea3d7",
      "members": [
        {
          "bel": "a(CHEBI:nicotine)",
          "concept": {
            "name": "nicotine",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "44ed555f78bacda2933ddef1d4280ce9"
        },
        {
          "bel": "p(CONSO:\"alpha-4-containing nAChR\")",
          "concept": {
            "name": "alpha-4-containing nAChR",
            "namespace": "CONSO"
          },
          "function": "Protein",
          "id": "f5c643bbd5a70416e56c39f2b2d495c2"
        }
      ]
    },
    {
      "bel": "composite(p(HGNC:CHRNA4), p(HGNC:CHRNB4))",
      "function": "Composite",
      "id": "90c8af25aed1392e288df0cada1c5e8f",
      "members": [
        {
          "bel": "p(HGNC:CHRNA4)",
          "concept": {
            "name": "CHRNA4",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "80f72d8d35ebd95851a4fbebf17fce4b"
        },
        {
          "bel": "p(HGNC:CHRNB4)",
          "concept": {
            "name": "CHRNB4",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "063b51f2ddde00e9de22ecd26754e1bb"
        }
      ]
    },
    {
      "bel": "composite(r(HGNC:CHRNA4), r(HGNC:CHRNB4))",
      "function": "Composite",
      "id": "658bfbb8b548183bdae5cc219f0332d8",
      "members": [
        {
          "bel": "r(HGNC:CHRNA4)",
          "concept": {
            "name": "CHRNA4",
            "namespace": "HGNC"
          },
          "function": "RNA",
          "id": "f67a00550d2f460b161560c12da975fc"
        },
        {
          "bel": "r(HGNC:CHRNB4)",
          "concept": {
            "name": "CHRNB4",
            "namespace": "HGNC"
          },
          "function": "RNA",
          "id": "7633a561415bf7a2d7d416c4decebfa9"
        }
      ]
    },
    {
      "bel": "p(CONSO:\"alpha-3 beta-2 nAChR\")",
      "concept": {
        "name": "alpha-3 beta-2 nAChR",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "158089e77070c7e21d4e0cca09c1a0db"
    },
    {
      "bel": "p(CONSO:\"alpha-4 beta-4 nAChR\")",
      "concept": {
        "name": "alpha-4 beta-4 nAChR",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "873b2da5332d7dcc0aeede964db13059"
    },
    {
      "bel": "p(CONSO:\"alpha-4-containing nAChR\")",
      "concept": {
        "name": "alpha-4-containing nAChR",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "f5c643bbd5a70416e56c39f2b2d495c2"
    },
    {
      "bel": "p(CONSO:\"alpha-6-containing nAChR\")",
      "concept": {
        "name": "alpha-6-containing nAChR",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "d62913a527d71e3f784b3ebc07aa837b"
    },
    {
      "bel": "p(CONSO:\"alpha-7-containing nAChR\")",
      "concept": {
        "name": "alpha-7-containing nAChR",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "f345684f49a458ac116337ace3fb3a87"
    },
    {
      "bel": "p(CONSO:\"alpha-Bungarotoxin\")",
      "concept": {
        "name": "alpha-Bungarotoxin",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "d6460fe2ee89d7c056254242689427e3"
    },
    {
      "bel": "p(CONSO:\"kappa-Bungarotoxin\")",
      "concept": {
        "name": "kappa-Bungarotoxin",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "784f82201aa248dda2d40cc3b0f21405"
    },
    {
      "bel": "p(FPLX:CHRN)",
      "concept": {
        "name": "CHRN",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "83ec6f28701674367e6d6be212520d7d"
    },
    {
      "bel": "p(HGNC:CHRNA4)",
      "concept": {
        "name": "CHRNA4",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "80f72d8d35ebd95851a4fbebf17fce4b"
    },
    {
      "bel": "p(HGNC:CHRNA6)",
      "concept": {
        "name": "CHRNA6",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "d804adefd120a8f6aaaf592407a91e06"
    },
    {
      "bel": "p(HGNC:CHRNB2)",
      "concept": {
        "name": "CHRNB2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7e5d65d97e555667e0928696d86663e6"
    },
    {
      "bel": "p(HGNC:CHRNB4)",
      "concept": {
        "name": "CHRNB4",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "063b51f2ddde00e9de22ecd26754e1bb"
    },
    {
      "bel": "path(MESH:\"Alzheimer Disease\")",
      "concept": {
        "name": "Alzheimer Disease",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "2ae8307f5fd59056199369691367cc96"
    },
    {
      "bel": "path(MESH:\"Tobacco Use Disorder\")",
      "concept": {
        "name": "Tobacco Use Disorder",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "13c7264761719693573e94c72e68fb16"
    },
    {
      "bel": "path(MESH:Affect)",
      "concept": {
        "name": "Affect",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "5aa2c69669d8aba462f474fcad63107f"
    },
    {
      "bel": "path(MESH:Epilepsy)",
      "concept": {
        "name": "Epilepsy",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "e790b858a85cda26640b78aeb308fe68"
    },
    {
      "bel": "path(MESH:Pleasure)",
      "concept": {
        "name": "Pleasure",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "ecf355fb0a22c6a303937b51d238a95d"
    },
    {
      "bel": "path(MESH:Reward)",
      "concept": {
        "name": "Reward",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "555fa782df944b9af1aada7a43eb9863"
    },
    {
      "bel": "path(MESH:Seizures)",
      "concept": {
        "name": "Seizures",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "70d77d326911c2a2fc35d764b4963e57"
    },
    {
      "bel": "r(HGNC:CHRNA4)",
      "concept": {
        "name": "CHRNA4",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "f67a00550d2f460b161560c12da975fc"
    },
    {
      "bel": "r(HGNC:CHRNA6)",
      "concept": {
        "name": "CHRNA6",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "b31b7a31b393b9a9db010e2ed1b84d55"
    },
    {
      "bel": "r(HGNC:CHRNB4)",
      "concept": {
        "name": "CHRNB4",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "7633a561415bf7a2d7d416c4decebfa9"
    }
  ]
}